Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Kuwait

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Kuwait Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20111
20133
20142
20163
20171
20192
20201
20211
20224
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status7
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dasman Diabetes Institute11
AstraZeneca3
Sanofi3
Novo Nordisk A/S2
George Washington University1
Janssen-Cilag International NV1
Kuwait University1
Novartis Pharmaceuticals1
Takeda1
University of Reading1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 225
Diabetes Mellitus3
Metabolic Diseases2
Acute Coronary Syndrome1
COVID-191
Diabetes Mellitus, Type 11
Feeding and Eating Disorders1
Glucose Metabolism Disorders1
Hypoglycemia1
Inflammation1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.